IGKV3D-20 and cancer: The quantification of immunosignals showed that α11 expression was significantly higher in cSCC in the in situ stage than in benign and premalignant skin lesions, which suggests that α11 could potentially be utilized as a novel early biomarker to improve the diagnosis and prognostication of this common human cancer.